Tarsus Pharmaceuticals Files Initial Beneficial Ownership Statement for Chief Commercial Officer Neera Clase

PUBT · 9h ago
Tarsus Pharmaceuticals Files Initial Beneficial Ownership Statement for Chief Commercial Officer Neera Clase
  • Tarsus Pharmaceuticals Chief Commercial Officer Neera Clase disclosed direct ownership of 14,800 common shares in an initial beneficial ownership statement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002162845-26-000004), on November 05, 2026, and is solely responsible for the information contained therein.